Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
LP-BM5 virus–infected mice produce activating autoantibodies to the AMPA receptor
Elena Koustova, Yoshitatsu Sei, Linda Fossom, Mei-Ling Wei, Peter N.R. Usherwood, N. Bradley Keele, Michael A. Rogawski, Anthony S. Basile
Elena Koustova, Yoshitatsu Sei, Linda Fossom, Mei-Ling Wei, Peter N.R. Usherwood, N. Bradley Keele, Michael A. Rogawski, Anthony S. Basile
View: Text | PDF
Article

LP-BM5 virus–infected mice produce activating autoantibodies to the AMPA receptor

  • Text
  • PDF
Abstract

Autoantibodies to α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptors may contribute to chronic hyperexcitability syndromes and neurodegeneration, but their origin is unclear. We examined LP-BM5 murine leukemia virus–infected mice, which manifest excitotoxic brain lesions and hypergammaglobulinemia, for the presence of AMPA-receptor Ab’s. Endogenous IgG accumulated upon neurons in the neocortex and caudate/putamen of infected mice and interacted with native and recombinant AMPA-receptor subunits with the following relative abundance: GluR3 ≥ GluR1 > GluR2 = GluR4, as determined by immunoprecipitation. In a radioligand assay, IgG preparations from infected mice specifically inhibited [3H]AMPA binding to receptors in brain homogenates, an activity that was lost after preadsorbing the IgG preparation to immobilized LP-BM5 virus. These IgGs also evoked currents when applied to hippocampal pyramidal neurons or to damaged cerebellar granule neurons. These currents could be blocked using any of several AMPA receptor antagonists. Thus, anti–AMPA-receptor Ab’s can be produced as the result of a virus infection, in part through molecular mimicry. These Ab’s may alter neuronal signaling and contribute to the neurodegeneration observed in these mice, actions that may be curtailed by the use of AMPA-receptor antagonists.

Authors

Elena Koustova, Yoshitatsu Sei, Linda Fossom, Mei-Ling Wei, Peter N.R. Usherwood, N. Bradley Keele, Michael A. Rogawski, Anthony S. Basile

×

Figure 2

Options: View larger image (or click on image) Download as PowerPoint
Immunoprecipitation reveals Ab’s to native GluR1 and GluR2/3 subunits in...
Immunoprecipitation reveals Ab’s to native GluR1 and GluR2/3 subunits in LP-BM5–infected mouse brain regions. High levels of GluR2/3 (b), and to a lesser extent, GluR1 subunits (a), were precipitated from supernatants of homogenates of cortex (CTX), striatum (STR), and cerebellum (CB) from uninfected (C) and LP-BM5–infected (M) mice using protein A–conjugated dextran beads (protein A precipitated, PAP). Faint bands corresponding to GluR4 (CB) (c), and NR1 (CTX, STR) (d), were also observed. No IgG/receptor subunit couplings were precipitated from the hippocampus (HPC, unprecipitated: Ctrl) despite the presence of GluR subunits.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts